Closed Loop Ventilation Strategy in Intensive Care Unit (ICU) Patients

NCT ID: NCT01472302

Last Updated: 2014-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

229 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adaptive support ventilation (ASV) is a closed loop ventilation mode that can act both like PCV and PSV automatically. Some studies suggest that ASV can reduce the weaning time in ICU patients. The investigators hypothesized that using ASV from the beginning of intubation can reduce the total duration of MV and LOS in the ICU when compared to conventional modes such as PCV+PSV

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Failure All Intubated Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ASV

Adaptive Support Ventilation

Group Type EXPERIMENTAL

Adaptive Support Ventilation

Intervention Type DEVICE

Ventilation protocol according to the patients ideal body weight

PCV

Pressure Controlled Ventilation

Group Type ACTIVE_COMPARATOR

Pressure Controlled Ventilation

Intervention Type DEVICE

Ventilation protocol (6-8 ml/kg tidal volume) according to our ICU

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adaptive Support Ventilation

Ventilation protocol according to the patients ideal body weight

Intervention Type DEVICE

Pressure Controlled Ventilation

Ventilation protocol (6-8 ml/kg tidal volume) according to our ICU

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intubated and mechanically ventilated ICU patients for more than 24 hours

Exclusion Criteria

* Patient with a tracheostomy
* Patients under home mechanical ventilation
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cenk Kirakli

Principal investigator, Director of ICU

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cenk Kirakli, MD

Role: PRINCIPAL_INVESTIGATOR

Izmir Dr. Suat Seren Chest Diseases and Surgery Training Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Izmir Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit

Izmir, Yenisehir, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Kirakli C, Naz I, Ediboglu O, Tatar D, Budak A, Tellioglu E. A randomized controlled trial comparing the ventilation duration between adaptive support ventilation and pressure assist/control ventilation in medical patients in the ICU. Chest. 2015 Jun;147(6):1503-1509. doi: 10.1378/chest.14-2599.

Reference Type DERIVED
PMID: 25742308 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IGCEAH-ICU 2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.